BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19626651)

  • 1. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
    Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
    Takamura M; Aoyagi Y
    Cancer; 2010 May; 116(10):2501; author reply 2501-2. PubMed ID: 20209613
    [No Abstract]   [Full Text] [Related]  

  • 3. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases.
    Hayashi Y; Osanai M; Lee GH
    Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
    Zhao WB; Li Y; Liu X; Zhang LY; Wang X
    Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
    Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of caveolin-1 gene in hepatitis B-related hepatocellular carcinoma and the clinical significance thereof].
    Yan J; Lu Q; Cai L; Li XW; Dong JH
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3272-4. PubMed ID: 19159553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
    Lee TK; Man K; Poon RT; Lo CM; Yuen AP; Ng IO; Ng KT; Leonard W; Fan ST
    Cancer Res; 2006 Oct; 66(20):9948-56. PubMed ID: 17047057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma.
    Hsieh SY; Huang SF; Yu MC; Yeh TS; Chen TC; Lin YJ; Chang CJ; Sung CM; Lee YL; Hsu CY
    Mol Carcinog; 2010 May; 49(5):476-87. PubMed ID: 20232364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
    Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
    Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.